KLK3 and posterior cortical atrophy: For instance, anxiety and uncertainty about disease progression can make PCa survivors opt out of AS and receive unnecessary treatments; anxiety was a significant predictor of treatment receipt among AS men, even when socio-demographics, baseline clinical characteristics, and Prostate-Specific Antigen (PSA) velocity were taken into account [11].